KRAS and pancreatic ductal adenocarcinoma: For instance, p62 overexpression induced by KRAS mutation activated NF‐κB signaling pathway and enhanced tumorigenesis in pancreatic ductal adenocarcinoma 6, and NRF2 activation by p62 contributed to tumor growth in hepatocellular carcinoma 7.